Skip to main content
Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 9.88
Day High 10.08
Open:10.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Today's Research Reports on Fennec Pharmaceuticals, CRH Medical, Cotinga Pharmaceuticals and Baylin Technologies
ACCESSWIRE - Thu Sep 27, 7:11AM CDT
ACCESSWIRE - CMTX
Thu Sep 27, 7:11AM CDT
NEW YORK, NY / ACCESSWIRE / September 27, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at and get exclusive access to our numerous research reports and market updates.
Fennec Provides Business Update and Announces Second Quarter 2018 Financial Results
GlobeNewswire - Mon Aug 13, 5:00AM CDT
GlobeNewswire - CMTX
Mon Aug 13, 5:00AM CDT
-- Publication of PEDMARK SIOPEL 6 Clinical Data in The New England Journal of Medicine
Fennec Pharmaceuticals Receives Positive Opinion on the Pediatric Investigation Plan From European Medicines Agency for PEDMARK(TM) and Confirmation of Eligibility for a Pediatric Use Marketing Authorization
GlobeNewswire - Tue Aug 7, 5:00AM CDT
GlobeNewswire - CMTX
Tue Aug 7, 5:00AM CDT
Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announced that the Pediatric Committee (PDCO) of the European Medicines Agency (EMA) has accepted the Company's pediatric investigation plan (PIP) for PEDMARK for the condition of the prevention of platinum-induced ototoxic hearing loss. The indication targeted by the PIP is for the prevention of platinum-induced ototoxic hearing loss for standard risk hepatoblastoma (SR-HB). Additional tumor types of the proposed indication will be subject to the Committee for Medicinal Products for Human Use (CHMP) assessment at the time of the Marketing Authorization Application (MAA). The company was also advised that PEDMARK is eligible for submission of an application for a Pediatric Use Marketing Authorisation (PUMA).
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 9.51 +3.89% increase
on 10/11/18
Period Open:10.63
Price movement based on the high, low and last over the given period.
11.00 -10.18% decrease
on 09/25/18
-0.75 (-7.06%) decrease
since 09/19/18
3-Month 9.51 +3.89% increase
on 10/11/18
Period Open:12.24
Price movement based on the high, low and last over the given period.
13.79 -28.35% decrease
on 08/13/18
-2.36 (-19.28%) decrease
since 07/18/18
52-Week 9.51 +3.89% increase
on 10/11/18
Period Open:13.04
Price movement based on the high, low and last over the given period.
18.86 -47.61% decrease
on 04/09/18
-3.16 (-24.23%) decrease
since 10/19/17

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement